Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Urolithin A, a novel natural compound to target PI3K/AKT/mTOR pathway in pancreatic cancer.

Totiger TM, Srinivasan S, Jala VR, Lamichhane P, Dosch AR, Gaidarski AA, Joshi C, Rangappa S, Castellanos J, Vemula PK, Chen X, Kwon D, Kashikar N, VanSaun M, Merchant NB, Nagathihalli NS.

Mol Cancer Ther. 2018 Nov 7. pii: molcanther.0464.2018. doi: 10.1158/1535-7163.MCT-18-0464. [Epub ahead of print]

PMID:
30404927
2.

Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium.

Kerlakian S, Dhar VK, Abbott DE, Kooby DA, Merchant NB, Kim HJ, Martin RC, Scoggins CR, Bentrem DJ, Weber SM, Maithel SK, Ahmad SA, Patel SH.

HPB (Oxford). 2018 Oct 23. pii: S1365-182X(18)34468-X. doi: 10.1016/j.hpb.2018.09.018. [Epub ahead of print]

PMID:
30361110
3.

Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer.

Srinivasan S, Totiger T, Shi C, Castellanos J, Lamichhane P, Dosch AR, Messaggio F, Kashikar N, Honnenahally K, Ban Y, Merchant NB, VanSaun M, Nagathihalli NS.

Cancer Res. 2018 Nov 1;78(21):6146-6158. doi: 10.1158/0008-5472.CAN-18-0579. Epub 2018 Sep 19.

PMID:
30232221
4.

Long-term Quality of Life and Gastrointestinal Functional Outcomes After Pancreaticoduodenectomy.

Allen CJ, Yakoub D, Macedo FI, Dosch AR, Brosch J, Dudeja V, Ayala R, Merchant NB.

Ann Surg. 2018 Oct;268(4):657-664. doi: 10.1097/SLA.0000000000002962.

PMID:
30199443
5.

Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.

Nagathihalli NS, Castellanos JA, Lamichhane P, Messaggio F, Shi C, Dai X, Rai P, Chen X, VanSaun MN, Merchant NB.

Cancer Res. 2018 Nov 1;78(21):6235-6246. doi: 10.1158/0008-5472.CAN-18-0634. Epub 2018 Aug 28.

PMID:
30154150
6.

Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study.

Dhar VK, Merchant NB, Patel SH, Edwards MJ, Wima K, Imbus J, Abbott DE, Weber SM, Louie R, Kim HJ, Martin RCG, Scoggins CR, Bentrem DJ, LeCompte MT, Idrees K, Lopez-Aguiar AG, Maithel SK, Kooby DA, Franco DA, Yakoub D, Ahmad SA.

Ann Surg. 2018 Sep;268(3):469-478. doi: 10.1097/SLA.0000000000002923.

PMID:
30063495
7.

Fine-Needle Aspiration-Based Grading of Pancreatic Neuroendocrine Neoplasms Using Ki-67: Is Accurate WHO Grading Possible on Cytologic Material?

Weiss VL, Kiernan C, Wright J, Merchant NB, Coogan AC, Shi C.

J Am Soc Cytopathol. 2018 May-Jun;7(3):154-459. doi: 10.1016/j.jasc.2018.02.001. Epub 2018 Feb 13.

PMID:
30038894
8.

NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.

Garg B, Giri B, Modi S, Sethi V, Castro I, Umland O, Ban Y, Lavania S, Dawra R, Banerjee S, Vickers S, Merchant NB, Chen SX, Gilboa E, Ramakrishnan S, Saluja A, Dudeja V.

Gastroenterology. 2018 Sep;155(3):880-891.e8. doi: 10.1053/j.gastro.2018.05.051. Epub 2018 Jul 29.

PMID:
29909021
9.

Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors.

Philips P, Kooby DA, Maithel S, Merchant NB, Weber SM, Winslow ER, Ahmad S, Kim HJ, Scoggins CR, McMasters KM, Martin RCG 2nd.

Pancreas. 2018 Mar;47(3):326-331. doi: 10.1097/MPA.0000000000000990.

PMID:
29351120
10.

Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth.

Messaggio F, Mendonsa AM, Castellanos J, Nagathihalli NS, Gorden L, Merchant NB, VanSaun MN.

Oncotarget. 2017 Aug 3;8(49):85378-85391. doi: 10.18632/oncotarget.19905. eCollection 2017 Oct 17.

11.

Bedside Rounds Valued But Not Preferred: Perceptions of Internal Medicine Residents and Attending Physicians in a Diverse Academic Training Program.

Merchant NB, Federman DG.

South Med J. 2017 Aug;110(8):531-537. doi: 10.14423/SMJ.0000000000000689.

PMID:
28771651
12.

Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional Study.

Wilson GC, Maithel SK, Bentrem D, Abbott DE, Weber S, Cho C, Martin RC, Scoggins CR, Kim HJ, Merchant NB, Kooby DA, Edwards MJ, Ahmad SA.

J Am Coll Surg. 2017 Apr;224(4):461-469. doi: 10.1016/j.jamcollsurg.2016.12.031. Epub 2017 Jan 11.

PMID:
28088598
13.

Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.

Nagathihalli NS, Castellanos JA, VanSaun MN, Dai X, Ambrose M, Guo Q, Xiong Y, Merchant NB.

Oncotarget. 2016 Oct 4;7(40):65982-65992. doi: 10.18632/oncotarget.11786.

14.

Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms.

Weiss V, Dueber J, Wright JP, Cates J, Revetta F, Parikh AA, Merchant NB, Shi C.

World J Gastrointest Oncol. 2016 Aug 15;8(8):615-22. doi: 10.4251/wjgo.v8.i8.615.

15.

Teaching at the Bedside: Managing Patient and Learner Expectations in Advance.

Merchant NB, Federman DG.

Ann Am Thorac Soc. 2016 Jun;13(6):994. doi: 10.1513/AnnalsATS.201602-140LE. No abstract available.

PMID:
27295167
16.

Perception Is Reality: quality metrics in pancreas surgery - a Central Pancreas Consortium (CPC) analysis of 1399 patients.

Abbott DE, Martin G, Kooby DA, Merchant NB, Squires MH, Maithel SK, Weber SM, Winslow ER, Cho CS, Bentrem DJ, Kim HJ, Scoggins CR, Martin RC, Parikh AA, Hawkins WG, Ahmad SA.

HPB (Oxford). 2016 May;18(5):462-9. doi: 10.1016/j.hpb.2015.11.006. Epub 2016 Mar 2.

17.

Eat When You Can, Sleep When You Can, and Don't Mess with the Pancreas.

Merchant NB.

Surg Oncol Clin N Am. 2016 Apr;25(2):xv-xvi. doi: 10.1016/j.soc.2016.01.001. No abstract available.

PMID:
27013375
18.

Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer.

Helmink BA, Snyder RA, Idrees K, Merchant NB, Parikh AA.

Surg Oncol Clin N Am. 2016 Apr;25(2):287-310. doi: 10.1016/j.soc.2015.11.008. Epub 2016 Feb 17. Review.

PMID:
27013365
19.

Patient-centred bedside rounds-exploring patient preferences before patient-centred care.

Merchant NB, Federman DG.

BMJ Qual Saf. 2016 Feb 29. pii: bmjqs-2016-005372. doi: 10.1136/bmjqs-2016-005372. [Epub ahead of print] No abstract available.

PMID:
26929444
20.

Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response.

Walsh AJ, Castellanos JA, Nagathihalli NS, Merchant NB, Skala MC.

Pancreas. 2016 Jul;45(6):863-9. doi: 10.1097/MPA.0000000000000543.

21.

Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.

Nagathihalli NS, Castellanos JA, Shi C, Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC, Moses HL, Merchant NB.

Gastroenterology. 2015 Dec;149(7):1932-1943.e9. doi: 10.1053/j.gastro.2015.07.058. Epub 2015 Aug 7.

22.

Peri-operative risk factors for delayed gastric emptying after a pancreaticoduodenectomy.

Robinson JR, Marincola P, Shelton J, Merchant NB, Idrees K, Parikh AA.

HPB (Oxford). 2015 Jun;17(6):495-501. doi: 10.1111/hpb.12385. Epub 2015 Feb 28.

23.

Strategies for Management of Synchronous Colorectal Metastases.

Castellanos JA, Merchant NB.

Curr Surg Rep. 2014 Jun 1;2:62.

24.

Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology Guidelines.

Kurtycz DF, Field A, Tabatabai L, Michaels C, Young N, Schmidt CM, Farrell J, Gopal D, Simeone D, Merchant NB, Pitman MB.

Cytojournal. 2014 Jun 2;11(Suppl 1):5. doi: 10.4103/1742-6413.133356. eCollection 2014.

25.

Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines.

Adler D, Schmidt CM, Al-Haddad M, Barthel JS, Ljung BM, Merchant NB, Romagnuolo J, Shaaban AM, Simeone D, Pitman MB, Layfield LJ.

Cytojournal. 2014 Jun 2;11(Suppl 1):1. doi: 10.4103/1742-6413.133326. eCollection 2014.

26.

Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.

Kooby DA, Lad NL, Squires MH 3rd, Maithel SK, Sarmiento JM, Staley CA, Adsay NV, El-Rayes BF, Weber SM, Winslow ER, Cho CS, Zavala KA, Bentrem DJ, Knab M, Ahmad SA, Abbott DE, Sutton JM, Kim HJ, Yeh JJ, Aufforth R, Scoggins CR, Martin RC, Parikh AA, Robinson J, Hashim YM, Fields RC, Hawkins WG, Merchant NB.

Ann Surg. 2014 Sep;260(3):494-501; discussion 501-3. doi: 10.1097/SLA.0000000000000890.

PMID:
25115425
27.

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

PMID:
25099441
28.

Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors.

Kauffmann RM, Wang L, Phillips S, Idrees K, Merchant NB, Parikh AA.

Ann Surg Oncol. 2014 Oct;21(11):3422-8. doi: 10.1245/s10434-014-3774-7. Epub 2014 Jul 25.

PMID:
25059786
29.

Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.

Sutton JM, Kooby DA, Wilson GC, Squires MH 3rd, Hanseman DJ, Maithel SK, Bentrem DJ, Weber SM, Cho CS, Winslow ER, Scoggins CR, Martin RC 2nd, Kim HJ, Baker JJ, Merchant NB, Parikh AA, Abbott DE, Edwards MJ, Ahmad SA.

J Gastrointest Surg. 2014 Sep;18(9):1575-87. doi: 10.1007/s11605-014-2567-4. Epub 2014 Jun 19.

PMID:
24944151
30.

Trends in the use of evidence-based therapy for resectable gastric cancer.

Snyder RA, Penson DF, Ni S, Koyama T, Merchant NB.

J Surg Oncol. 2014 Sep;110(3):285-90. doi: 10.1002/jso.23635. Epub 2014 May 30.

31.

Hepatic uterus-like mass misdiagnosed as hepatic abscess.

Sopha SC, Rosado FG, Smith JJ, Merchant NB, Shi C.

Int J Surg Pathol. 2015 Apr;23(2):134-9. doi: 10.1177/1066896914534465. Epub 2014 May 13.

PMID:
24827588
32.

Postbrushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: the Papanicolaou Society of Cytopathology guidelines.

Kurtycz D, Tabatabai ZL, Michaels C, Young N, Schmidt CM, Farrell J, Gopal D, Simeone D, Merchant NB, Field A, Pitman MB; Papanicolaou Society of Cytopathology.

Diagn Cytopathol. 2014 Apr;42(4):363-71. doi: 10.1002/dc.23121.

33.

Loss of HNF6 expression correlates with human pancreatic cancer progression.

Pekala KR, Ma X, Kropp PA, Petersen CP, Hudgens CW, Chung CH, Shi C, Merchant NB, Maitra A, Means AL, Gannon MA.

Lab Invest. 2014 May;94(5):517-27. doi: 10.1038/labinvest.2014.47. Epub 2014 Mar 17.

34.

Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: the Papanicolaou Society of Cytopathology recommendations for pancreatic and biliary cytology.

Adler D, Max Schmidt C, Al-Haddad M, Barthel JS, Ljung BM, Merchant NB, Romagnuolo J, Shaaban AM, Simeone D, Bishop Pitman M, Field A, Layfield LJ; Papanicolaou Society of Cytopathology.

Diagn Cytopathol. 2014 Apr;42(4):325-32. doi: 10.1002/dc.23095. Epub 2014 Feb 19.

35.

Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Nagathihalli NS, Beesetty Y, Lee W, Washington MK, Chen X, Lockhart AC, Merchant NB.

Cancer Res. 2014 Apr 1;74(7):2062-72. doi: 10.1158/0008-5472.CAN-13-2329. Epub 2014 Feb 11.

36.

Gastric duplication cyst masquerading as a mucinous pancreatic cyst: case report and literature review.

Bailey CE, Fritz MB, Webb L, Merchant NB, Parikh AA.

Ann R Coll Surg Engl. 2014 Jan;96(1):88E-90E. doi: 10.1308/003588414X13824511649977. Review.

PMID:
24417851
37.

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association.

Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, Macari M, Megibow AJ, Miller FH, Mortele KJ, Merchant NB, Minter RM, Tamm EP, Sahani DV, Simeone DM.

Gastroenterology. 2014 Jan;146(1):291-304.e1. doi: 10.1053/j.gastro.2013.11.004.

PMID:
24355035
38.

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association.

Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, Macari M, Megibow AJ, Miller FH, Mortele KJ, Merchant NB, Minter RM, Tamm EP, Sahani DV, Simeone DM.

Radiology. 2014 Jan;270(1):248-60. doi: 10.1148/radiol.13131184.

PMID:
24354378
39.

Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.

Sopha SC, Gopal P, Merchant NB, Revetta FL, Gold DV, Washington K, Shi C.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2476-86. eCollection 2013.

40.

Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.

Mikhitarian K, Pollen M, Zhao Z, Shyr Y, Merchant NB, Parikh A, Revetta F, Washington MK, Vnencak-Jones C, Shi C.

Mod Pathol. 2014 May;27(5):665-74. doi: 10.1038/modpathol.2013.185. Epub 2013 Nov 1.

41.

Intensity of follow-up after pancreatic cancer resection.

Castellanos JA, Merchant NB.

Ann Surg Oncol. 2014 Mar;21(3):747-51. doi: 10.1245/s10434-013-3289-7. Epub 2013 Oct 4. Review.

42.

Surgical care and career opportunities in a changing practice paradigm.

Tepas JJ 3rd, Hughes TG Sr, Aaronson DS, Kesler JL, Buckley RJ, Dippolito AJ, Wall MJ, Merchant NB, Dandridge WC, Sinanan MN, Buchbinder D, Sussman HL, Hayes-Jordan A, Chen JC, Wetstein L, Arbutina DR, Dennehy JC 3rd, Alseidi A, Rege RV, Fink AS, Barney LM, Cloyd DW, Fallat ME, Loeff DS, Behrns KE, Vickers SM.

J Am Coll Surg. 2013 Oct;217(4):711-717.e1. doi: 10.1016/j.jamcollsurg.2013.05.031. No abstract available.

PMID:
24054411
43.

Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells.

Castellanos JA, Merchant NB, Nagathihalli NS.

Onco Targets Ther. 2013 Sep 13;6:1261-7. doi: 10.2147/OTT.S34670. Review.

44.

Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma.

Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, Merchant NB, Washington MK, Zhang B, Shyr Y, Deane NG, Beauchamp RD.

PLoS One. 2013 Jul 29;8(7):e69660. doi: 10.1371/journal.pone.0069660. Print 2013.

45.

Evidence for enhanced telomerase activity in Barrett's esophagus with dysplasia and adenocarcinoma.

Merchant NB, Dutta SK, Girotra M, Arora M, Meltzer SJ.

Asian Pac J Cancer Prev. 2013;14(2):679-83.

46.

Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?

Kelly KJ, Winslow E, Kooby D, Lad NL, Parikh AA, Scoggins CR, Ahmad S, Martin RC, Maithel SK, Kim HJ, Merchant NB, Cho CS, Weber SM.

J Gastrointest Surg. 2013 Jul;17(7):1209-17; discussion 1217. doi: 10.1007/s11605-013-2178-5. Epub 2013 Apr 26.

PMID:
23620151
47.

Terminal ileal carcinoid tumor without hepatic or extrahepatic metastasis causing carcinoid syndrome.

Datta J, Merchant NB.

Am Surg. 2013 Apr;79(4):439-41. No abstract available.

PMID:
23574858
48.

53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma.

Ausborn NL, Wang T, Wentz SC, Washington MK, Merchant NB, Zhao Z, Shyr Y, Chakravarthy AB, Xia F.

BMC Cancer. 2013 Mar 26;13:155. doi: 10.1186/1471-2407-13-155.

49.

Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma.

Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB.

World J Gastrointest Oncol. 2012 Oct 15;4(10):207-15. doi: 10.4251/wjgo.v4.i10.207.

50.

Commentary: The role of global surgery electives during residency training: relevance, realities, and regulations.

Axt J, Nthumba PM, Mwanzia K, Hansen E, Tarpley MJ, Krishnaswami S, Nwomeh BC, Holterman AX, Nadler EP, Simeone D, Orloff S, Tarpley JL, Merchant NB.

Surgery. 2013 Mar;153(3):327-32. doi: 10.1016/j.surg.2012.09.014. Epub 2012 Dec 27. No abstract available.

PMID:
23274100

Supplemental Content

Loading ...
Support Center